Pfizer Inc, Cary, North Carolina 27513, USA.
Pain Med. 2013 Aug;14(8):1173-86. doi: 10.1111/pme.12148. Epub 2013 Jun 7.
To compare the pharmacodynamic effects, including self-reports of "drug liking" and "high," of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules (MSN), crushed morphine sulfate controlled-release (CR) tablets, and placebo in an abuse potential study.
Randomized, double-blind, placebo-controlled, three-way crossover study.
Single-center.
Nondependent recreational opioid users.
Orally administered crushed MSN (120-mg morphine sulfate and 4.8-mg naltrexone hydrochloride), crushed 120-mg morphine sulfate CR, and placebo.
Subjective ratings (100-point visual analog scales) of positive drug effects (drug liking, high, good effects, take drug again, and overall drug liking), any effects, and negative effects (bad effects, feel sick, nausea, sleepy, and dizzy), along with pupillometry, pharmacokinetic (PK), and safety assessments.
Crushed morphine sulfate CR significantly increased ratings of all positive subjective measures relative to placebo (P < 0.0001). Crushed MSN significantly decreased all positive subjective ratings compared with morphine sulfate CR (P ≤ 0.005), but significantly increased ratings compared with placebo (P < 0.03). Peak pupil diameter was significantly larger for MSN than morphine sulfate (P < 0.0001). PK analysis of morphine plasma concentrations indicated that Cmax was significantly lower and tmax significantly longer for crushed MSN compared with crushed morphine sulfate CR. Plasma concentrations of naltrexone and 6-β-naltrexol were present following crushed MSN.
This study demonstrated that when crushed and administered orally to nondependent recreational opioid users, MSN was associated with significantly lower scores on all positive subjective measures including drug liking and high, and significantly less pupil constriction compared with crushed morphine sulfate CR.
比较硫酸吗啡控释片(CR)粉碎后与纳曲酮盐酸盐缓释胶囊(MSN)粉碎后、硫酸吗啡粉碎后及安慰剂在药物滥用倾向研究中的药效学效应,包括“药物喜好”和“快感”的自我报告。
随机、双盲、安慰剂对照、三向交叉研究。
单中心。
非依赖型娱乐性阿片类药物使用者。
口服给予粉碎后的 MSN(120mg 硫酸吗啡和 4.8mg 纳曲酮盐酸盐)、粉碎后的 120mg 硫酸吗啡 CR 和安慰剂。
阳性药物效应(药物喜好、快感、良好效应、再次服用药物和总体药物喜好)、任何效应和负性效应(不良效应、恶心、呕吐、嗜睡和头晕)的主观评分(100 点视觉模拟量表),以及瞳孔测量、药代动力学(PK)和安全性评估。
硫酸吗啡 CR 粉碎后与安慰剂相比,所有阳性主观测量的评分均显著增加(P<0.0001)。与吗啡 CR 粉碎后相比,MSN 粉碎后显著降低了所有阳性主观评分(P≤0.005),但与安慰剂相比,评分显著增加(P<0.03)。MSN 的瞳孔直径峰值明显大于吗啡(P<0.0001)。吗啡血浆浓度 PK 分析表明,与吗啡 CR 粉碎后相比,MSN 粉碎后 Cmax 显著降低,tmax 显著延长。MSN 粉碎后存在纳曲酮和 6-β-纳曲醇的血浆浓度。
本研究表明,当粉碎后口服给予非依赖型娱乐性阿片类药物使用者时,与吗啡 CR 粉碎后相比,MSN 与所有阳性主观测量指标(包括药物喜好和快感)的评分显著降低,瞳孔收缩显著减少。